| Today's Open | $36.44 |
|---|---|
| Previous Close | $36.32 |
| Daily Range | $35.62 - $36.81 |
| 52-Week Range | $19.03 - $39.00 |
| Market Cap | $4.5B |
| P/E Ratio | -74.12 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 418,957 |
| Average Daily Volume | 828,492 |
| Current FY EPS | -$0.82 |
Sector
Healthcare
Industry
Drugs
Seattle Genetics, Inc. (SGEN) Description
A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seagen.com/
News & Commentary
Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Supplemental BLA Accepted for Filing by t
Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog
Narrower-than-Expected Loss at Seattle Genetics - Analyst BlogSGEN's Top Competitors
(1.05%)
(0.63%)
(2.44%)
(-0.50%)